Decrease of hyperglycemia by syringaldehyde in diabetic rats

Hormone and Metabolic Research

Volumn 46, Issue 1, 2014, Pages 8-13

  Kuo, S C ^a,b   Chung, H H ^c   Huang, C H ^b   Cheng, J T ^a,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

diabetes; glucose infusion rate; hyperinsulinemic euglycemic clamp; postprandial glucose; syringaldehyde

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 4; LIGNIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STREPTOZOCIN; SYRINGALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; DIABETES MELLITUS; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; HIBISCUS; HIBISCUS TAIWANENSIS; HYPERGLYCEMIA; MALE; NONHUMAN; PLANT STEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

HIBISCUS TAIWANENSIS; MALVACEAE; RATTUS;

ANIMALS; BENZALDEHYDES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FRUCTOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; LIVER; MALE; MUSCLE, SKELETAL; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); POSTPRANDIAL PERIOD; RATS; RATS, WISTAR;

EID: 84892513646     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351274     Document Type: Article

References (45)

1. Jeffcoate S. L. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med: 2004; 21 657 665
2. Zimmet P., Alberti K. G., Shaw J. Global and societal implications of the diabetes epidemic. Nature: 2001; 414 782 787
3. Avitabile N. A., Banka A., Fonseca V. A. Glucose control and cardiovascular outcomes in individuals with diabetes mellitus: lessons learned from the megatrials. Heart Fail Clin: 2012; 8 513 522
4. Jarab A. S., Alqudah S. G., Mukattash T. L., Shattat G., Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in jordan. J Manag Care Pharm: 2012; 18 516 526
5. Kim Y., Babu A. R. Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes. Diabetes Metab Syndr Obes: 2012; 5 313 327
6. Lindström J., Louheranta A., Mannelin M., Rastas M., Salminen V., Eriksson J., Uusitupa M., Tuomilehto J. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care: 2003; 26 3230 3236
7. Perreault L., Pan Q., Mather K. J., Watson K. E., Hamman R. F., Kahn S. E. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet: 2012; 379 2243 2251
8. El-Sayed M. I. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol: 2011; 137 643 651
9. Liao Z., Chen X., Wu M. Antidiabetic effect of flavones from Cirsium japonicum DC in diabetic rats. Arch Pharm Res: 2010; 33 353 362
10. Lee S., Monnappa A. K., Mitchell R. J. Biological activities of lignin hydrolysate-related compounds. BMB Rep: 2012; 45 265 274
11. Shen C. C., Ni C. L., Shen Y. C., Huang Y. L., Kuo C. H., Wu T. S., Chen C. C. Phenolic constituents from the stem bark of Magnolia officinalis. J Nat Prod: 2009; 72 168 171
12. Michalska K., Kisiel W. The first guaian-12-oic acid glucopyranosyl ester and other constituents from Picris rhagadioloides (L.) Desf. (Asteraceae). Molecules: 2008; 13 444 451
13. Guchu E., Diaz-Maroto M. C., Diaz-Maroto I. J., Vila-Lameiro P., Perez-Coello M. S. Influence of the species and geographical location on volatile composition of Spanish oak wood (Quercus petraea Liebl. and Quercus robur L.). J Agric Food Chem: 2006; 54 3062 3066
14. Huang C. H., Chen M. F., Chung H. H., Cheng J. T. Antihyperglycemic effect of syringaldehyde in streptozotocin-induced diabetic rats. J Nat Prod: 2012; 75 1465 1468
15. Liu I. M., Chang C. K., Juang S. W., Kou D. H., Tong Y. C., Cheng K. C., Cheng J. T. Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int J Exp Pathol: 2008; 89 292 300
16. Chen Y. W., Hsieh P. L., Chen Y. C., Hung C. H., Cheng J. T. Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats. Anesth Analg: 2013; 116 482 490
17. Chiu Y. J., Chung H. H., Yeh C. H., Cheng J. T., Lo S. H. Improvement of Insulin Resistance by Chlorella in Fructose-rich Chow-fed Rats. Phytother Res: 2011; 25 1306 1312
18. Lai D. M., Tu Y. K., Liu I. M., Chen P. F., Cheng J. T. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med: 2006; 72 9 13
19. Matsuo T., Odaka H., Ikeda H. Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes. Am J Clin Nutr: 1992; 55 1 Suppl 314S 317S
20. Kim S. H., Jo S. H., Kwon Y. I., Hwang J. K. Effects of Onion (Allium cepa L.) Extract Administration on Intestinal alpha-Glucosidases Activities and Spikes in Postprandial Blood Glucose Levels in SD Rats Model. Int J Mol Sci: 2011; 12 3757 3769
21. Su C. H., Liu I. M., Chung H. H., Cheng J. T. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett: 2009; 457 125 128
22. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci: 1959; 82 420 430
23. Hwang S. L., Liu I. M., Tzeng T. F., Cheng J. T. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia: 2005; 48 767 775
24. Luo X., Zhang Y., Ruan X., Jiang X., Zhu L., Wang X., Ding Q., Liu W., Pan Y., Wang Z., Chen Y. Fasting-induced protein phosphatase 1 regulatory subunit contributes to postprandial blood glucose homeostasis via regulation of hepatic glycogenesis. Diabetes: 2011; 60 1435 1445
25. Giugliano D., Ceriello A., Esposito K. Glucose metabolism and hyperglycemia. Am J Clin Nutr: 2008; 87 217S 222S
26. Woerle H. J., Albrecht M., Linke R., Zschau S., Neumann C., Nicolaus M., Gerich J., Göke B., Schirra J. Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab: 2008; 294 E103 E109
27. Maggs D., MacDonald I., Nauck M. A. Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes. Diabetes Obes Metab: 2008; 10 18 33
28. Mitrakou A. Kidney: its impact on glucose homeostasis and hormonal regulation. Diabetes Res Clin Pract: 2011; 93 01 S66 S72
29. Kowluru R. A., Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes: 2004; 53 3233 3238
30. Mah E., Bruno R. S. Postprandial hyperglycemia on vascular endothelial function: mechanisms and consequences. Nutr Res: 2012; 32 727 740
31. Klosterbuer A. S., Thomas W., Slavin J. L. Resistant starch and pullulan reduce postprandial glucose, insulin, and GLP-1, but have no effect on satiety in healthy humans. J Agric Food Chem: 2012; 60 11928 11934
32. Hsu C. H. Different impacts of metabolic syndrome components on insulin resistance in type 2 diabetes. Int J Endocrinol: 2013; 2013 740419
33. Konstantopoulos N., Molero J. C., McGee S. L., Spolding B., Connor T., de Vries M., Wanyonyi S., Fahey R., Morrison S., Swinton C., Jones S., Cooper A., Garcia-Guerra L., Foletta V. C., Krippner G., Andrikopoulos S., Walder K. R. Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo. Diabetes: 2012; 61 2146 2154
34. Li Y., Chen M., Xuan H., Hu F. Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med: 2012; 2012 981896
35. Gan K. X., Wang C., Chen J. H., Zhu C. J., Song G. Y. Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats. World J Gastroenterol: 2013; 19 1572 1581
36. Ko W. C., Liu I. M., Chung H. H., Cheng J. T. Activation of I(2)-imidazoline receptors may ameliorate insulin resistance in fructose-rich chow-fed rats. Neurosci Lett: 2008; 448 90 93
37. Consoli A., Nurjhan N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes: 1989; 38 550 557
38. Friedrichsen M., Mortensen B., Pehmoller C., Birk J. B., Wojtaszewski J. F. Exercise-induced AMPK activity in skeletal muscle: Role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol: 2013; 366 204 214
39. Kaidanovich-Beilin O., Eldar-Finkelman H. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. J Pharmacol Exp Ther: 2006; 316 17 24
40. Yang Q., Graham T. E., Mody N., Preitner F., Peroni O. D., Zabolotny J. M., Kotani K., Quadro L., Kahn B. B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature: 2005; 436 356 362
41. Bi Y., Sun W. P., Chen X., Li M., Liang H., Cai M. Y., Zhu Y. H., He X. Y., Xu F., Weng J. P. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol: 2008; 45 167 178
42. Berger J., Biswas C., Vicario P. P., Strout H. V., Saperstein R., Pilch P. F. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature: 1989; 340 70 72
43. Shieh J. P., Cheng K. C., Chung H. H., Kerh Y. F., Yeh C. H., Cheng J. T. Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats. J Agric Food Chem: 2011; 59 3747 3753
44. Cheng J. T., Huang C. C., Liu I. M., Tzeng T. F., Chang C. J. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes: 2006; 55 819 825
45. Zhang Y., Wang Z., Zhao Y., Zhao M., Wang S., Hua Z., Zhang J. The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice. Am J Physiol Endocrinol Metab: 2012; 302 E325 E333